M31.0 classifies hypersensitivity angiitis, an immune-mediated necrotizing vasculopathy of small vessels, and explicitly includes Goodpasture's syndrome (anti-glomerular basement membrane disease) as an applicable condition under this code.
Verified May 8, 2026 · 7 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- Other
Documentation tips
What should appear in the chart to support M31.0.
Source · Editorial brief grounded in 7 cited references ↓
- Provider must explicitly document 'hypersensitivity angiitis,' 'Goodpasture's syndrome,' or 'anti-GBM disease' — a generic 'vasculitis' or 'angiitis NOS' is insufficient and will land on a less-specific code.
- For Goodpasture's syndrome, confirm the record contains serological findings (anti-GBM antibody titer) and/or biopsy results showing linear IgG deposition along the glomerular basement membrane to defend M31.0 on audit.
- Document organ involvement explicitly (renal, pulmonary, or both) — additional codes for glomerulonephritis or pulmonary hemorrhage may be appropriate if those manifestations are not considered integral to the syndrome.
- If the diagnosis is still under investigation (suspected, possible, rule out), follow outpatient coding guidelines and code the presenting signs or symptoms rather than M31.0 until the diagnosis is confirmed.
- Note any trigger or antigen exposure (drug, infection, foreign substance) in the clinical note — this supports the hypersensitivity mechanism and reinforces M31.0 over other vasculitis codes.
Related CPT procedures
Procedure codes commonly billed with M31.0. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M31.0 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Coding to the non-billable parent M31 (Other necrotizing vasculopathies) instead of the specific billable M31.0 — claims submitted with M31 will reject.
- Using I77.6 (Arteritis, unspecified) when the record clearly documents hypersensitivity angiitis — I77.6 is excluded from the M30–M36 block by a Type 2 Excludes note, meaning M31.0 is the correct home when the condition falls within systemic connective tissue disorders.
- Conflating leukocytoclastic cutaneous vasculitis with hypersensitivity angiitis without a provider diagnosis — these share clinical features but require distinct provider documentation to support M31.0.
- Assigning M31.0 for Goodpasture's syndrome based on lab findings alone without a physician-documented diagnosis — code assignment requires provider attestation, not coder interpretation of lab values.
- Failing to code co-existing organ-specific manifestations (e.g., glomerulonephritis, pulmonary hemorrhage) when those conditions are documented and not considered integral to the syndrome per facility guidelines.
Clinical context
Source · Editorial summary grounded in 7 cited references ↓
M31.0 sits within the Other Necrotizing Vasculopathies category (M31) under Systemic Connective Tissue Disorders (M30–M36). Use it when the documented diagnosis is hypersensitivity angiitis — an immune complex–driven inflammatory process targeting small vessel walls — or when the provider explicitly documents Goodpasture's syndrome (anti-GBM disease), which is the most common named entity mapped here. The Alphabetic Index routes both 'hypersensitivity angiitis' and 'anti-glomerular basement membrane disease' to M31.0.
Goodpasture's syndrome involves circulating autoantibodies directed against the non-collagenous domain of type IV collagen in glomerular and alveolar basement membranes. Clinically it presents with pulmonary alveolar hemorrhage and rapidly progressive glomerulonephritis. For coding purposes, the provider's documented diagnosis drives code selection — you do not need to independently interpret the serologic or biopsy findings, but those findings should be present in the chart to support the diagnosis if audited.
M31.0 is the terminal, billable code — do not code to the parent M31 (non-billable). When a patient has manifestations of both renal and pulmonary involvement, additional codes for those organ-specific findings may be assigned if they are not considered integral to the syndrome per coding guidelines. Distinguish M31.0 from leukocytoclastic cutaneous vasculitis (which shares MeSH overlap but may map differently depending on provider documentation) and from thrombotic microangiopathy (M31.1), which requires distinct clinical findings such as microangiopathic hemolytic anemia and thrombocytopenia.
Inclusion & exclusion notes
Per the official ICD-10-CM Tabular List.
Source · CDC ICD-10-CM Official Tabular List · 2026
Includes
- Goodpasture's syndrome
Sibling codes
Other billable codes under M31 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 7 cited references ↓
01Is Goodpasture's syndrome the same code as hypersensitivity angiitis?
02Can I use M31.0 for leukocytoclastic vasculitis?
03Why shouldn't I use I77.6 (Arteritis, unspecified) when the chart mentions arteritis in a patient with hypersensitivity angiitis?
04Do I need a biopsy to code M31.0?
05Should I add codes for kidney or lung involvement when coding M31.0 for Goodpasture's syndrome?
06Is M31.0 valid for FY2026?
07What is the parent code of M31.0 and why can't I bill it?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (FY2026, effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M30-M36/M31-/M31.0
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M31.0
- 04unboundmedicine.comhttps://www.unboundmedicine.com/icd/view/ICD-10-CM/866340/all/M31_0___Hypersensitivity_angiitis
- 05icdlist.comhttps://icdlist.com/icd-10/M31.0
- 06cdek.pharmacy.purdue.eduhttps://cdek.pharmacy.purdue.edu/icd10/M31.0/
- 07cms.govhttps://www.cms.gov/Medicare/Coding/ICD10/Downloads/2019-ICD10-Coding-Guidelines-.pdf
Mira AI Scribe
Mira captures the provider's explicit diagnosis (hypersensitivity angiitis or Goodpasture's syndrome), documented organ involvement (renal, pulmonary, or both), and supporting findings such as anti-GBM antibody results or biopsy confirmation of linear IgG deposition. This prevents downgrade to a nonspecific vasculitis code, blocks use of the non-billable parent M31, and supplies the audit trail needed to defend M31.0 if payer documentation requests are received.
See how Mira captures M31.0 documentation